论文部分内容阅读
目的 :为了探讨Denver管腹腔颈静脉转流术对临床上难治性肝硬化腹水治疗的近期及远期疗效。方法 :我院自 1 994年 2月以来共治疗肝炎后肝硬化顽固性腹水病人 1 7例 ,其中术后一周内死亡 3例 ( 2例DIC ,1例心衰 ) ,总有效率为 82 3% ( 1 4 / 1 7)。本文对Denver置管术后 1 4例出院病人进行了 4— 6年疗效随访。结果 :现存活 3例 ,占 2 1 4 2 % ,1 1例已死亡 ,其中最长生存期为 2 2月 ,最短生存期为 3月 ,平均为 1 0 51± 7 0 4月。通过对 1 4例术后的体重、腹围、尿量、肝功能、输注白蛋白用量以及B超等多方面比较 ,可以看出患者的生活质量明显地提高。结论 :Denver管是顽固性腹水治疗的有效方法之一
Objective : To investigate the short-term and long-term efficacy of Denver tube in the treatment of refractory cirrhosis with ascites. METHODS: In our hospital since February 1994, a total of 17 cases of refractory hepatic cirrhosis with ascites were treated. Among them, 3 died within one week after operation (2 cases of DIC and 1 case of heart failure). The total effective rate was 82 3 . % ( 1 4 / 1 7). In this article, 4 to 6 years of follow-up of Denver catheterized patients after discharge were performed. RESULTS: Three patients survived, accounting for 2.142%, and 11 patients died. The longest survival period was February, and the shortest survival period was March, with an average of 1 0 51 ± 7 0 4 months. Through the comparison of postoperative weight, abdominal circumference, urine volume, liver function, infusion of albumin, and B ultrasound, it can be seen that the patient’s quality of life is significantly improved. Conclusion : Denver tube is one of the effective methods to treat refractory ascites